ADGM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Adagio Medical Holdings Inc (ADGM) is not a strong buy at the moment for a beginner investor with a long-term focus. While there is some positive sentiment from hedge fund buying and promising news about its ULTA technology, the company's financial performance is extremely weak, with revenue at zero and significant losses. Additionally, there are no strong proprietary trading signals, and technical indicators do not suggest a clear entry point. Given the lack of substantial growth catalysts and poor financials, holding off on this stock is recommended.
The MACD is positive and expanding, indicating some bullish momentum. However, RSI is in the neutral zone at 77.148, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 1.152, with resistance at 1.31 and support at 0.994.
Hedge funds are significantly increasing their buying activity, up 1972.62% over the last quarter. Additionally, the company has completed 13 ventricular ablation procedures using its ULTA technology, which could be a promising development in treating refractory arrhythmias.
The company's financial performance is highly concerning, with revenue dropping to zero (-100% YoY) and gross margin also at zero. Net income remains negative, and EPS is still in the red despite some improvement. Insiders are neutral, and there is no recent congress trading data to indicate influential support.
In Q3 2025, revenue dropped to zero (-100% YoY), gross margin also fell to zero, and net income increased to -$10,118,000 (up 118.58% YoY). EPS improved to -0.66 (up 106.25% YoY), but the overall financial health of the company remains poor.
No data on analyst ratings or price target changes is available for this stock.
